These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2418226)

  • 21. [A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].
    Andresen D; von Leitner ER; Wegscheider K; Schröder R
    Z Kardiol; 1984 Aug; 73(8):492-7. PubMed ID: 6208699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of oral pirmenol in suppressing ventricular premature depolarisations.
    de Buitleir M; Crevey B; Johnson T; Baerman J; Morady F
    Ir Med J; 1987 Feb; 80(2):60-3. PubMed ID: 2435676
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical significance and therapy of extrasystole].
    Kettner W
    Z Arztl Fortbild (Jena); 1978 Dec; 72(23):1105-9. PubMed ID: 84445
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recurrent ventricular tachycardia studied by Holter's method (author's transl)].
    Faniel R; Friart J
    Rev Med Brux; 1980 Mar; 1(3):165-8. PubMed ID: 6162180
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of ventricular extrasystole].
    Seipel L
    Dtsch Med Wochenschr; 1989 Oct; 114(41):1571-5. PubMed ID: 2478353
    [No Abstract]   [Full Text] [Related]  

  • 26. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease].
    Dobrotvorskaia TE; Rybakova MK; Suprun EK; Arifullin ShS
    Ter Arkh; 1992; 64(12):30-2. PubMed ID: 1284005
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of experimental and clinical methods on the effectiveness and side effect profile of anti-arrhythmia agents].
    Kuck KH
    Z Kardiol; 1992; 81 Suppl 4():151-5. PubMed ID: 1283932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Unsustainable lightness of Holter monitoring].
    Sanna G
    G Ital Cardiol; 1988 Oct; 18(10):815-8. PubMed ID: 3073095
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of short-term drug testing as part of a systematic approach for evaluation of antiarrhythmic drugs.
    Podrid PJ; Lown B; Graboys TB; Lampert S
    Circulation; 1986 Feb; 73(2 Pt 2):II81-91. PubMed ID: 3943177
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacodynamics and pharmacokinetics of loracainide, a new anti-arrhythmia agent].
    Meinertz T; Kasper W; Kersting F; Just H; Jähnchen E
    Verh Dtsch Ges Inn Med; 1978; (84):1477-9. PubMed ID: 84447
    [No Abstract]   [Full Text] [Related]  

  • 32. [Combination therapy with anti-arrhythmia agents].
    Kettner W; Götze C
    Z Arztl Fortbild (Jena); 1986; 80(21):889-92. PubMed ID: 2436386
    [No Abstract]   [Full Text] [Related]  

  • 33. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative evaluation of the anti-arrhythmic activity of carbamazepine, novocainamide and obzidan in ventricular extrasystole].
    Logosha IuI; Kamalova EG; Khusainova FS
    Farmakol Toksikol; 1986; 49(6):71-3. PubMed ID: 2434357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methods for evaluating anti-arrhythmia drugs in man].
    Lekieffre J; Libersa C; Caron J; Kacet S; Marchand X
    Rev Prat; 1986 Nov; 36(53):3115-8, 3121-9. PubMed ID: 3809930
    [No Abstract]   [Full Text] [Related]  

  • 36. ECG of the month. High anxiety. Ventricular ectopic activity.
    Martinez-Lopez JI
    J La State Med Soc; 1989 May; 141(5):5, 7-8. PubMed ID: 2471763
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cordanum in the treatment of ischemic heart disease with stable extrasystole in the middle-aged and elderly].
    Korkushko OV; Butenko AG; Shatilo VB
    Sov Med; 1986; (8):3-8. PubMed ID: 2430340
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
    Dobrotvorskaia TE; Koroleva ON; Gordina OV; Marakanova AV
    Klin Med (Mosk); 1996; 74(3):51-3. PubMed ID: 8926706
    [No Abstract]   [Full Text] [Related]  

  • 39. Does therapy directed by programmed electrical stimulation provide a satisfactory clinical response?
    Friedman L; Yusuf S
    Circulation; 1986 Feb; 73(2 Pt 2):II59-66. PubMed ID: 3510768
    [No Abstract]   [Full Text] [Related]  

  • 40. [Phase I and II studies in the development of a new anti-arrhythmia drug].
    Jaillon P
    Therapie; 1986; 41(2):81-6. PubMed ID: 3726794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.